1. Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P, The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee 2003 Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 143:415-421

2. Wit J, Rekers-Mombarg LT, Crowe RJ, Roberts K, Gill AM, Attanasio AF 2003 Growth hormone (GH) significantly increases final height in patients with non-GH deficient short stature. Pediatr Res 53:154

3. Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinley MJ 2000 A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 342:1633-1637

4. Mauras N, George D, Evans J, Milov D, Abrams S, Rini A, Welch S, Haymond MW 2002 Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study. Metabolism 51:127-135

5. Touati G, Prieur AM, Ruiz JC, Noel M, Czernichow P 1998 Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition. J Clin Endocrinol Metab 83:403-409

6. Hardin DS, Stratton R, Kramer JC, Reyes de la Rocha,S., Govaerts K, Wilson DP 1998 Growth hormone improves weight velocity and height velocity in prepubertal children with cystic fibrosis. Horm Metab Res 30:636-641

7. Hardin DS, Ellis KJ, Dyson M, Rice J, McConnell R, Seilheimer DK 2001 Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial. J Pediatr 139:636-642

8. Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, Tansil S, New MI 2005 Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 90:3318-3325

9. Growth Hormone Research Society 2000 Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 85:3990-3993

10. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL 2000 CDC growth charts: United States. Adv Data (314):1-27

11. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z 2001 Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res 11:137-165

12. Greulich W, Pyle S 1959 Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford: Stanford University Press;

13. Tanner JM, Whitehouse R, Marshall WA, Healy MJR, Goldstein H 1975 Assessment of skeletal maturity and prediction of adult height (TW2 Method). London: Academic Press;

14. Bayley N 1946 Tables for predicting adult height from present height and skeletal age. J Pediatr 28:49

15. Rosenfield R, Cutler L 2001 Somatic Growth and Maturation. In: Jameson JL, Burger HG, eds. Endocrinology. Philadelphia: W.B. Saunders; 477-502

16. Underwood LE, Van Wyk JJ 1992 Normal and Aberrant Growth. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. Philadelphia: W.B. Saunders; 1079-1138

17. Greulich W, Pyle S 1950 Radiographic atlas of skeletal development of the hand and wrist. In: Anonymous Stanford: Stanford University Press; 190

18. Bayley N, Pinneau SR 1952 Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 40:423-441

19. Roche AF, Wainer H, Thissen D 1975 The RWT method for the prediction of adult stature. Pediatrics 56:1027-1033

20. Zachmann M, Sobradillo B, Frank M, Frisch H, Prader A 1978 Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions. J Pediatr 93:749-755

21. Salerno M, Balestrieri B, Matrecano E, Officioso A, Rosenfeld RG, Di Maio S, Fimiani G, Ursini MV, Pignata C 2001 Abnormal GH receptor signaling in children with idiopathic short stature. J Clin Endocrinol Metab 86:3882-3888

22. Blethen SL, Breen TJ, Attie KM 1996 Overview of the National Cooperative Growth Study substudy of serial growth hormone measurements. J Pediatr 128:S38-41

23. Root AW, Kemp SF, Rundle SC, Dana K, Attie K 1998 Effect of long-term recombinant growth hormone therapy in children - The National Cooperative Growth Study, USA, 1985-1994. J Pediatr Endocrinol Metab 11:403-412

24. Faglia G, Arosio M, Porretti S 2000 Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up? J Endocrinol Invest 23:721-723

25. Dunkel L, Wickman S 2002 Novel treatment of delayed male puberty with aromatase inhibitors. Horm Res 57 Suppl 2:44-52

26. Zung A, Zadik Z 2002 New approaches in the treatment of short stature. Harefuah 141:1059-65, 1089

27. Hero M, Norjavaara E, Dunkel L 2005 Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab 90:6396-6402

28. Tuffli GA, Johanson A, Rundle AC, Allen DB 1995 Lack of increased risk for extracranial, nonleukemic neoplasms in recipients of recombinant deoxyribonucleic acid growth hormone. J Clin Endocrinol Metab 80:1416-1422

29. Cowell CT, Dietsch S 1995 Adverse events during growth hormone therapy. J Pediatr Endocrinol Metab 8:243-252

30. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R 1996 Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience. J Clin Endocrinol Metab 81:1704-1710

31. Clayton PE, Cowell CT 2000 Safety issues in children and adolescents during growth hormone therapy--a review. Growth Horm IGF Res 10:306-317

32. Eiholzer U 2005 Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res 63:33-39

33. Gerard JM, Garibaldi L, Myers SE, Aceto T,Jr, Kotagal S, Gibbons VP, Stith J, Weber C 1997 Sleep apnea in patients receiving growth hormone. Clin Pediatr (Phila) 36:321-326

34. Lindgren AC, Hellstrom LG, Ritzen EM, Milerad J 1999 Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr 158:936-940

35. Miller J, Silverstein J, Shuster J, Driscoll DJ, Wagner M 2006 Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome. J Clin Endocrinol Metab 91:413-417

36. Maneatis T, Baptista J, Connelly K, Blethen S 2000 Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 13 Suppl 2:1035-1044

37. Moshang T,Jr, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A 1996 Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128:S4-7

38. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL 2002 Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87:3136-3141

39. Savage MO, Camacho-Hubner C, Dunger DB 2004 Therapeutic applications of the insulin-like growth factors. Growth Horm IGF Res 14:301-308

40. Laron Z, Anin S, Klipper-Aurbach Y, Klinger B 1992 Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 339:1258-1261

41. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Blum WF, Wilton P 1995 Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results. Horm Res 44:253-264

42. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Wilton P 1999 Long-term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European Multicentre Study. The Working Group on Growth Hormone Insensitivity Syndromes. Horm Res 51:128-134

43. Laron Z 2004 Insulin-like growth factor-I (lGF-l): safety and efficacy. Pediatr Endocrinol Rev 2 Suppl 1:78-85

44. Backeljauw PF, Underwood LE, GHIS Collaborative Group. Growth hormone insensitivity syndrome 2001 Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study. J Clin Endocrinol Metab 86:1504-1510

45. Larsen WJ 1997 Human Embryology. London: Churchill Livingstone;

46. Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, Marcos E, Duriez B, Cacheux V, Moers A, Goossens M, Gruters A, Amselem S 2000 Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 25:182-186

47. Bhangoo AP, Hunter CS, Savage JJ, Anhalt H, Pavlakis S, Walvoord EC, Ten S, Rhodes SJ 2006 Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency. J Clin Endocrinol Metab 91:747-753

48. Raetzman LT, Ward R, Camper SA 2002 Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 129:4229-4239

49. Sobrier ML, Attie-Bitach T, Netchine I, Encha-Razavi F, Vekemans M, Amselem S 2004 Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development. Gene Expr Patterns 5:279-284

50. Machinis K, Pantel J, Netchine I, Leger J, Camand OJ, Sobrier ML, Dastot-Le Moal F, Duquesnoy P, Abitbol M, Czernichow P, Amselem S 2001 Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 69:961-968

51. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS, Robinson IC 1998 Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19:125-133

52. Carvalho LR, Woods KS, Mendonca BB, Marcal N, Zamparini AL, Stifani S, Brickman JM, Arnhold IJ, Dattani MT 2003 A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J Clin Invest 112:1192-1201

53. Parks JS, Brown MR, Hurley DL, Phelps CJ, Wajnrajch MP 1999 Heritable disorders of pituitary development. J Clin Endocrinol Metab 84:4362-4370

54. Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, Zacharin M, Cameron F, Hurst J, Woods K, Dunger D, Stanhope R, Forrest S, Robinson IC, Beddington RS 2001 Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 10:39-45

55. Rosenbloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS 1999 Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab 84:50-57

56. Turton JP, Mehta A, Raza J, Woods KS, Tiulpakov A, Cassar J, Chong K, Thomas PQ, Eunice M, Ammini AC, Bouloux PM, Starzyk J, Hindmarsh PC, Dattani MT 2005 Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clin Endocrinol (Oxf) 63:10-18

57. Pfaffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van den Brande JL, Rosenfeld MG, Ingraham HA 1992 Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257:1118-1121

58. Turton JP, Reynaud R, Mehta A, Torpiano J, Saveanu A, Woods KS, Tiulpakov A, Zdravkovic V, Hamilton J, Attard-Montalto S, Parascandalo R, Vella C, Clayton PE, Shalet S, Barton J, Brue T, Dattani MT 2005 Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 90:4762-4770

59. Dattani MT 2005 Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clin Endocrinol (Oxf) 63:121-130

60. Rizzoti K, Brunelli S, Carmignac D, Thomas PQ, Robinson IC, Lovell-Badge R 2004 SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet 36:247-255

61. Foster JW, Graves JA 1994 An SRY-related sequence on the marsupial X chromosome: implications for the evolution of the mammalian testis-determining gene. Proc Natl Acad Sci U S A 91:1927-1931

62. Stevanovic M, Lovell-Badge R, Collignon J, Goodfellow PN 1993 SOX3 is an X-linked gene related to SRY. Hum Mol Genet 2:2013-2018

63. Collignon J, Sockanathan S, Hacker A, Cohen-Tannoudji M, Norris D, Rastan S, Stevanovic M, Goodfellow PN, Lovell-Badge R 1996 A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 122:509-520

64. Laumonnier F, Ronce N, Hamel BC, Thomas P, Lespinasse J, Raynaud M, Paringaux C, Van Bokhoven H, Kalscheuer V, Fryns JP, Chelly J, Moraine C, Briault S 2002 Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet 71:1450-1455

65. Woods KS, Cundall M, Turton J, Rizotti K, Mehta A, Palmer R, Wong J, Chong WK, Al-Zyoud M, El-Ali M, Otonkoski T, Martinez-Barbera JP, Thomas PQ, Robinson IC, Lovell-Badge R, Woodward KJ, Dattani MT 2005 Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 76:833-849

66. Goossens M, Brauner R, Czernichow P, Duquesnoy P, Rappaport R 1986 Isolated growth hormone (GH) deficiency type 1A associated with a double deletion in the human GH gene cluster. J Clin Endocrinol Metab 62:712-716

67. Wagner JK, Eble A, Hindmarsh PC, Mullis PE 1998 Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency. Pediatr Res 43:105-110

68. Wajnrajch MP, Gertner JM, Harbison MD, Chua SC,Jr, Leibel RL 1996 Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 12:88-90

69. Binder G, Nagel BH, Ranke MB, Mullis PE 2002 Isolated GH deficiency (IGHD) type II: imaging of the pituitary gland by magnetic resonance reveals characteristic differences in comparison with severe IGHD of unknown origin. Eur J Endocrinol 147:755-760

70. Mullis PE, Robinson IC, Salemi S, Eble A, Besson A, Vuissoz JM, Deladoey J, Simon D, Czernichow P, Binder G 2005 Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up study. J Clin Endocrinol Metab 90:2089-2096

71. Cogan JD, Ramel B, Lehto M, Phillips J,3rd, Prince M, Blizzard RM, de Ravel TJ, Brammert M, Groop L 1995 A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency--a clinical research center study. J Clin Endocrinol Metab 80:3591-3595

72. Takahashi Y, Shirono H, Arisaka O, Takahashi K, Yagi T, Koga J, Kaji H, Okimura Y, Abe H, Tanaka T, Chihara K 1997 Biologically inactive growth hormone caused by an amino acid substitution. J Clin Invest 100:1159-1165

73. McCarthy EMS, Phillips JAI 1997 Characterization of the intron splice site enhancer that regulated splicing of human growth hormone pre-mRNA.

74. Cogan JD, Prince MA, Lekhakula S, Bundey S, Futrakul A, McCarthy EM, Phillips JA,3rd 1997 A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet 6:909-912

75. Hayashi Y, Yamamoto M, Ohmori S, Kamijo T, Ogawa M, Seo H 1999 Inhibition of growth hormone (GH) secretion by a mutant GH-I gene product in neuroendocrine cells containing secretory granules: an implication for isolated GH deficiency inherited in an autosomal dominant manner. J Clin Endocrinol Metab 84:2134-2139

76. Kamijo T, Hayashi Y, Seo H, Ogawa M 1999 Hereditary isolated growth hormone deficiency caused by GH1 gene mutations in Japanese patients. Growth Horm IGF Res 9 Suppl B:31-4

77. Wajnrajch M, Gertner JM, Mullis PE, et al 2000 Ar138His, a new mutational hot-spot in the growth hormone gene causing Isolated GH Deficiency Type II. J Endocrin Genet 1:124-134

78. Lee MS, Wajnrajch MP, Kim SS, Plotnick LP, Wang J, Gertner JM, Leibel RL, Dannies PS 2000 Autosomal dominant growth hormone (GH) deficiency type II: the Del32-71-GH deletion mutant suppresses secretion of wild-type GH. Endocrinology 141:883-890

79. Vivenza D, Guazzarotti L, Godi M, Frasca D, di Natale B, Momigliano-Richiardi P, Bona G, Giordano M 2006 A novel deletion in the GH1 gene including the IVS3 branch site responsible for autosomal dominant isolated growth hormone deficiency. J Clin Endocrinol Metab 91:980-986

80. Fintini D, Salvatori R, Salemi S, Otten B, Ubertini G, Cambiaso P, Mullis PE 2006 Autosomal-dominant isolated growth hormone deficiency (IGHD type II) with normal GH-1 gene. Horm Res 65:76-82

81. Veldhuis JD, Roemmich JN, Rogol AD 2000 Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females--a general clinical research center-based study. J Clin Endocrinol Metab 85:2385-2394

82. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F 1996 An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 81:2460-2467

83. Roemmich JN, Clark PA, Weltman A, Veldhuis JD, Rogol AD 2005 Pubertal alterations in growth and body composition: IX. Altered spontaneous secretion and metabolic clearance of growth hormone in overweight youth. Metabolism 54:1374-1383

84. Rivier J, Spiess J, Thorner M, Vale W 1982 Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300:276-278

85. Gonzalez-Crespo S, Boronat A 1991 Expression of the rat growth hormone-releasing hormone gene in placenta is directed by an alternative promoter. Proc Natl Acad Sci U S A 88:8749-8753

86. Mayo KE, Cerelli GM, Lebo RV, Bruce BD, Rosenfeld MG, Evans RM 1985 Gene encoding human growth hormone-releasing factor precursor: structure, sequence, and chromosomal assignment. Proc Natl Acad Sci U S A 82:63-67

87. Mayo KE 1992 Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol Endocrinol 6:1734-1744

88. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE 1993 GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232

89. Lin SC, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG 1993 Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364:208-213

90. Wajnrajch MP, Chua SC, Green ED, Leibel RL 1994 Human growth hormone-releasing hormone receptor (GHRHR) maps to a YAC at chromosome 7p15. Mamm Genome 5:595

91. Baumann G, Maheshwari H 1997 The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. Acta Paediatr Suppl 423:33-38

92. Netchine I, Talon P, Dastot F, Vitaux F, Goossens M, Amselem S 1998 Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. J Clin Endocrinol Metab 83:432-436

93. Salvatori R, Hayashida CY, Aguiar-Oliveira MH, Phillips JA,3rd, Souza AH, Gondo RG, Toledo SP, Conceicao MM, Prince M, Maheshwari HG, Baumann G, Levine MA 1999 Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab 84:917-923

94. Wajnrajch MP, Gertner JM, Sokoloff AS, Ten I, Harbison MD, Netchine I, Maheshwari HG, Goldstein DB, Amselem S, Baumann G, Leibel RL 2003 Haplotype analysis of the growth hormone releasing hormone receptor locus in three apparently unrelated kindreds from the indian subcontinent with the identical mutation in the GHRH receptor. Am J Med Genet A 120:77-83

95. Desai MP, Upadhye PS, Kamijo T, Yamamoto M, Ogawa M, Hayashi Y, Seo H, Nair SR 2005 Growth hormone releasing hormone receptor (GHRH-r) gene mutation in Indian children with familial isolated growth hormone deficiency: a study from western India. J Pediatr Endocrinol Metab 18:955-973

96. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stokvis-Brantsma WH, Wit JM 2001 Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 86:2459-2464

97. Bowers CY, Chang J, Momany FA, Folkers K 1977 Effects of the enkephalins and enkephalin-analog on release of pituitary hormones in vitro. 6th International Conference on Endocrinology, North Holland,

98. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660

99. Wajnrajch M, Ten I, Gertner JM, Leibel RL 2000 Genomic organization of the GHRELIN gene. J Endocrin Genet 1:231-233

100. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977

101. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K 2000 Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911

102. Bercu B, Walker RF 1997 Novel growth hormone secretagogues: clinical applications. Endocrinologist 7:51-64

103. Giustina A, Bonfanti C, Licini M, Ragni G, Stefana B 1997 Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone. Regul Pept 70:49-54

104. Tolis G, Karydis I, Markousis V, Karagiorga M, Mesimeris T, Lenaerts V, Deghenghi R 1997 Growth hormone release by the novel GH releasing peptide hexarelin in patients with homozygous beta-thalassemia. J Pediatr Endocrinol Metab 10:35-40

105. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K 2001 A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86:4552

106. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E 2000 Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23:493-495

107. Ghizzoni L, Mastorakos G, Vottero A, Ziveri M, Ilias I, Bernasconi S 2004 Spontaneous growth hormone (GH) secretion is not directly affected by ghrelin in either short normal prepubertal children or children with GH neurosecretory dysfunction. J Clin Endocrinol Metab 89:5488-5495

108. Racine MS, Symons KV, Foster CM, Barkan AL 2004 Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone. J Clin Endocrinol Metab 89:3326-3331

109. Hirsh D, Heinrichs C, Leenders B, Wong AC, Cummings DE, Chanoine JP 2005 Ghrelin is suppressed by glucagon and does not mediate glucagon-related growth hormone release. Horm Res 63:111-118

110. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ 2005 Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996-999

111. Ukkola O, Ravussin E, Jacobson P, Snyder EE, Chagnon M, Sjostrom L, Bouchard C 2001 Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 86:3996-3999

112. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S 2006 Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116:760-768

113. Grossman A, Savage MO, Lytras N, Preece MA, Sueiras-Diaz J, Coy DH, Rees LH, Besser GM 1984 Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults. Clin Endocrinol (Oxf) 21:321-330

114. Date Y, Murakami N, Kojima M, Kuroiwa T, Matsukura S, Kangawa K, Nakazato M 2000 Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 275:477-480

115. Shen LP, Pictet RL, Rutter WJ 1982 Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sci U S A 79:4575-4579

116. Rosskopf D, Schurks M, Manthey I, Joisten M, Busch S, Siffert W 2003 Signal transduction of somatostatin in human B lymphoblasts. Am J Physiol Cell Physiol 284:C179-90

117. Laron Z 1995 Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J Clin Endocrinol Metab 80:1526-1531

118. Dastot F, Sobrier ML, Duquesnoy P, Duriez B, Goossens M, Amselem S 1996 Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein. Proc Natl Acad Sci U S A 93:10723-10728

119. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724

120. Binder G, Baur F, Schweizer R, Ranke MB 2006 The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 91:659-664

121. Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJ 2006 Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 91:1076-1080

122. Pilotta A, Mella P, Filisetti M, Felappi B, Prandi E, Parrinello G, Notarangelo LD, Buzi F 2006 Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 91:1178-1180

123. Ayling RM, Ross R, Towner P, Von Laue S, Finidori J, Moutoussamy S, Buchanan CR, Clayton PE, Norman MR 1997 A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat Genet 16:13-14

124. Amselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, Postel-Vinay MC, Goossens M 1989 Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 321:989-995

125. Woods KA, Fraser NC, Postel-Vinay MC, Savage MO, Clark AJ 1996 A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab 81:1686-1690

126. Woods KA, Dastot F, Preece MA, Clark AJ, Postel-Vinay MC, Chatelain PG, Ranke MB, Rosenfeld RG, Amselem S, Savage MO 1997 Phenotype: genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 82:3529-3535

127. Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LM 1995 Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med 333:1093-1098

128. Bonioli E, Taro M, Rosa CL, Citana A, Bertorelli R, Morcaldi G, Gastaldi R, Coviello DA 2005 Heterozygous mutations of growth hormone receptor gene in children with idiopathic short stature. Growth Horm IGF Res 15:405-410

129. Rosenbloom AL, Guevara Aguirre J, Rosenfeld RG, Fielder PJ 1990 The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador. N Engl J Med 323:1367-1374

130. Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Diamond FB,Jr, Rosenfeld RG 1993 Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations. J Clin Endocrinol Metab 76:417-423

131. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367

132. Bonapace G, Concolino D, Formicola S, Strisciuglio P 2003 A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 40:913-917

133. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doorn J, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA, Wit JM 2005 Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 90:2855-2864

134. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72

135. Morison IM, Reeve AE 1998 Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications. Mol Med Today 4:110-115

136. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 96:7324-7329

137. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 96:7088-7092

138. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781

139. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566

140. Pollak M 2000 Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36:1224-1228

141. Jernstrom H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M, Narod SA 2001 Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab 72:144-154

142. Cohen P, Clemmons DR, Rosenfeld RG 2000 Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10:297-305

143. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512

144. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82

145. Roback EW, Barakat AJ, Dev VG, Mbikay M, Chretien M, Butler MG 1991 An infant with deletion of the distal long arm of chromosome 15 (q26.1----qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Genet 38:74-79

146. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD, Intrauterine Growth Retardation (IUGR) Study Group 2003 IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211-2222

147. Fitzpatrick GV, Soloway PD, Higgins MJ 2002 Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat Genet 32:426-431

148. Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A 1997 Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 11:3128-3142

149. McElreavey K, Fellous M 1997 Sex-determining genes. Trends Endocrinol Metab 8:342-5

150. Fisher AM, Thomas NS, Cockwell A, Stecko O, Kerr B, Temple IK, Clayton P 2002 Duplications of chromosome 11p15 of maternal origin result in a phenotype that includes growth retardation. Hum Genet 111:290-296

151. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, Danton F, Thibaud N, Le Merrer M, Burglen L, Bertrand AM, Netchine I, Le Bouc Y 2005 Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 37:1003-1007

152. Schonherr N, Meyer E, Eggermann K, Ranke MB, Wollmann HA, Eggermann T 2006 (Epi)mutations in 11p15 significantly contribute to Silver-Russell syndrome: but are they generally involved in growth retardation? Eur J Med Genet 49:414-418

153. Hannula K, Lipsanen-Nyman M, Kontiokari T, Kere J 2001 A narrow segment of maternal uniparental disomy of chromosome 7q31-qter in Silver-Russell syndrome delimits a candidate gene region. Am J Hum Genet 68:247-253